Data as of Sep 19
| +0.08 / +1.21%|
The 4 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 8.50, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a +26.68% increase from the last price of 6.71.
The current consensus among 4 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.